2013 AACR: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent

4 November 2013/in 2013, Guadecitabine (SGI-110) – (Hematological Malignancies and Solid Tumors), Products

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2013-11-04 16:34:012016-11-25 16:34:262013 AACR: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent

Useful links

Home
Sitemap
Privacy Policy
Terms of Use
Legal

Member of the Otsuka Group

A selection of photos on this website
is courtesy of Valerio Berdini

2013 AACR: Evaluation oral bioavailability and intermittent dosing schedule...2013 AACR: Novel Small Molecule DNA Methylation Inhibitor SGI-110 as Ovarian...

Scroll to top

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok